Live
FierceBiotechAscendis axes IL-2 program in retreat from oncology expansionPharmaVoiceNovo hikes guidance on Wegovy pill’s fast sales startEndpoints NewsAmgen adds $300M to Puerto Rico budget; Novartis to exit oral drug factory in GermanyFierceBiotechEntrada's stock craters as DMD data underperform expectations, handing advantage to NovartisFierceBiotechRoche shells out up to $1B for PathAI in move to boost artificial intelligence-powered diagnosticsPromega BlogWhat Counts as EvidenceFierceBiotechFrom drug development to M&A, Big Pharmas showcase AI’s ‘measurable impact’Lonza NewsBMS Licenses SYNtecan Linker-Payload Platform from Lonza - Contract PharmaIlluminaAi In Genomics Market Is Going to Boom | Illumina, IBM, Google - openPR.comEndpoints NewsAtara, Pierre Fabre's cell therapy to get another shot at FDA approvalFierceBiotechInsulet boosts guidance in Q1 update as it grapples with recall sagaPharmaVoiceLilly, Gilead lead pharma’s M&A boom

Archives

Récent Plus ancien Effacer
@Lonza News
Total 194
Source Lonza News
Recherche --